Neuroone Medical Technologies (NMTC) Gross Profit Growth (1y) (2012 - 2026)
Neuroone Medical Technologies (NMTC) Gross Profit Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 15.74% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 27.39% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -1.74% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.30% |
| 10 | Neuroone Medical Technologies | 14.85 Mn | 12.05 Mn | 990,264.00 | 28.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.43% |
| Dec 31, 2025 | -18.63% |
| Sep 30, 2025 | 983.65% |
| Jun 30, 2025 | 224.56% |
| Mar 31, 2025 | 97.50% |
| Dec 31, 2024 | 623.54% |
| Sep 30, 2024 | -27.16% |
| Jun 30, 2024 | 15.68% |
| Mar 31, 2024 | 1,139.31% |
| Dec 31, 2023 | 2,263.92% |
| Sep 30, 2023 | 1,385.72% |
| Jun 30, 2023 | 3,899.56% |
| Mar 31, 2023 | 186.97% |
| Dec 31, 2022 | 6.02% |
| Sep 30, 2022 | 12.07% |
| Jun 30, 2022 | 70.64% |
| Mar 31, 2022 | -71.49% |
| Dec 31, 2021 | 65.22% |
| Jun 30, 2014 | -32.82% |
| Mar 31, 2014 | -59.36% |